BAALC Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of BAALC Antibodies for investigating the BAALC protein's role in cellular processes. BAALC Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BAALC, or Brain and Acute Leukemia, Cytoplasmic protein, plays a significant role in regulating cell growth and differentiation, particularly in hematopoietic cells. BAALC expression patterns have been linked to acute myeloid leukemia and various other malignancies, making it an important focus in cancer research. Studying BAALC functionality can reveal crucial insights into tumor biology and lead to innovative therapeutic approaches. Researchers can utilize BAALC monoclonal antibodies to explore cellular signaling pathways and molecular mechanisms in both normal and disease states. Advanced detection methods, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates, enable precise visualization and quantification of BAALC. Santa Cruz Biotechnology monoclonal antibodies for BAALC research support scientists worldwide in advancing our understanding of cancer biology and developing potential therapeutic strategies.